Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cybin Inc
(NY:
CYBN
)
9.880
-0.460 (-4.45%)
Official Closing Price
Updated: 8:00 PM EDT, Sep 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cybin Inc
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
37
38
Next >
PsychedelicNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) CYB004 Demonstrates Significant Advantages over IV and Inhaled DMT in Pharmacokinetic Study
April 13, 2022
Via
Investor Brand Network
Cybin's CYB0004 Shows Positive Preclinical Results Over Traditional Psychedelics
April 13, 2022
CYB004 is one of Cybin’s (NYSE: CYBN) proprietary second-generation psychedelics, developed to treat depression, anxiety, and ...
Via
Benzinga
Why Psychedelics Could Soon Replace Antidepressants
April 13, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 13, 2022 – Anxiety disorders are the most common mental illness in the US, affecting approximately 40 million adults...
Via
FinancialNewsMedia
Cybin Announces Positive CYB004 Data Demonstrating Significant Advantages Over Intravenous and Inhaled DMT
April 13, 2022
From
Cybin Inc.
Via
Business Wire
Psychedelic Stock Gainers And Losers From April 11, 2022
April 11, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 4.52% at $0.17
Via
Benzinga
Performance Comparisons Of The 5 Cannabis Sector Categories
April 10, 2022
Here is a summary of how each of the 5 categories in the cannabis sector performed over four time periods, to highlight the different category trends that are underway.
Via
Talk Markets
Revive Therapeutics, Cybin Among Top Psychedelic Movers Of Today
April 08, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.54% at $0.16
Via
Benzinga
WIPO Publishes Cybin's Patent Application For Inhaled Psychedelics Therapies
April 08, 2022
Cybin Inc. (NYSE: CYBN) announced that the World Intellectual Property Organization (WIPO) published an international patent ...
Via
Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Strengthens IP Position Of Psychedelic Programs
April 08, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Strengthens IP Position of Psychedelic Programs
April 08, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Further Strengthens Long-Term IP Position of Psychedelic-Based Programs
April 08, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Strengthening Foothold in Multibillion-Dollar Mental Health Space
April 08, 2022
Via
Investor Brand Network
Cybin Announces Publication of International PCT Patent Application for Inhalation Delivery of Multiple Psychedelic Molecules
April 08, 2022
From
Cybin Inc.
Via
Business Wire
Revive Therapeutics, Field Trip Health Among Top Psychedelic Movers Of Today
April 07, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.48% at $0.14
Via
Benzinga
Cybi (NEO: CYBN) (NYSE American: CYBN) To Participate In Benzinga Psychedelics Conference
April 07, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Cybi (NEO: CYBN) (NYSE American: CYBN) to Participate in Benzinga Psychedelics Conference
April 07, 2022
Via
Investor Brand Network
Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today
April 06, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 4.78% at $19.73 LOSERS:
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) to Participate in Upcoming Benzinga Psychedelics Capital Conference
April 06, 2022
Via
Investor Brand Network
A Builder From The Ground Up, Doug Drysdale, CEO of Cybin: Meet Our Speakers
April 06, 2022
From his beginnings at DuPont Merck to his current position as Cybin’s (NYSE: CYBN) CEO, Doug Drysdale has certainly had an ...
Via
Benzinga
Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!
April 06, 2022
It’s earnings week in the psychedelics space, opening a new window into the financial situations of many companies in the sector.
Via
Benzinga
Cybin to Present at the Benzinga Psychedelics Capital Conference in Miami on April 19, 2022
April 06, 2022
From
Cybin Inc.
Via
Business Wire
Psychedelic Stock Gainers And Losers From April 5, 2022
April 05, 2022
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 1.60% at $1.27 LOSERS:
Via
Benzinga
Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
April 04, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 6.06% at $14.18
Via
Benzinga
Cybin's (NYSE American: CYBN) (NEO: CYBN) Adelia Therapeutics Achieves New Milestone
April 04, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Cybin’s (NYSE American: CYBN) (NEO: CYBN) Adelia Therapeutics Achieves New Milestone
April 04, 2022
Via
Investor Brand Network
3 Psychedelic Stocks to Buy for Oregon’s Magic Mushroom Bill
April 04, 2022
Psychedelic medical treatments and therapies are gaining in popularity, and these psychedelic stocks could benefit as the market emerges.
Via
InvestorPlace
Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today
April 01, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 5.26% at $0.86
Via
Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Announces Commencement Of Kernel Flow(R) Study
April 01, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) Adelia Therapeutics Inc. Achieves New Milestone
April 01, 2022
Via
Investor Brand Network
Cybin (NYSE American: CYBN) (NEO: CYBN) Announces Commencement of Kernel Flow(R) Study
April 01, 2022
Via
Investor Brand Network
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
37
38
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.